Curie.Bio is a founder-focused seed-stage venture firm combined with an industry-grade therapeutics accelerator focused on one thing: helping entrepreneurial founders launch viable therapeutics companies. Curie.Bio does this by giving founders access to a team of the world’s best drug hunters and drug makers, seed capital, and best-of-breed services - everything a founder needs to get from concept to a compelling quality dataset that enables an awesome Series A financing. In a nutshell, we want founders in control of their own company and focused on their area of expertise and creativity, while we help make the rest happen smoothly.

Curie.Bio

No one understands the needs of a biotech founder better than someone who just went through their own founder journey. Curie.Bio is proud to welcome Leah Sibener, Ph.D. to the CSO Partner Team as a copilot for founders. Leah co-founded and built 3T Biosciences, a therapeutics company spinout leveraging her Ph.D. work in Chris Garcia's lab at Stanford. To learn more about Leah and how she'll support founders, read her bio at the link below.

https://lnkd.in/e_kzC6XR

Join us at the 2024 Convergence Forum, where Curie.Bio CEO Zach Weinberg will be speaking alongside Steve Pagliuca (Arena Bioworks) and Daphne Zohar (PureTech Health) to discuss new models for launching therapeutics companies. 

Meeting agenda → https://lnkd.in/eqtP66Au

We're thrilled to welcome Dallas Jones to our CSO Partner Team as a copilot for the founders of our portfolio companies. Dallas provides a wealth of experience after leading multiple programs from early-stage drug discovery through clinical development in Immunology and Neuroscience through his experience at Merck and Abide Therapeutics. He also supported the launch of multiple Series A therapeutics companies at Inception Sciences, the discovery engine of Versant Ventures. To learn more about Dallas and how he'll support founders, read his bio at the link below.

https://lnkd.in/eDzkV-4q

After an illustrious career bringing 11 drugs to the clinic, we're proud to announce Darryl B. McConnell has joined Curie.Bio as a CXO in Residence to help founders of our portfolio companies create successful medicines. To learn more about Darryl and how he'll be supporting founders, read his bio at the link below.

https://lnkd.in/eFCiv99K

"Do you have a therapeutic idea worthy of funding?" Our goal is to be every founder's first phone call. Whether you reach out through a warm intro or our website, you'll get specific and candid feedback from our team. At Curie.Bio, all ideas go through the same process regardless of where they come from. Connect with us at www.curie.bio

https://lnkd.in/ee4tA35i

AbCellera Biologics Inc is a publicly traded biotech company utilizing AI-based research platforms for drug discovery.

AbCellera Biologics Inc

BenevolentAI is a company utilizing AI-driven drug discovery software for drug discovery and development.

BenevolentAI

Forward Therapeutics, Inc. is a biotech company with a unique AI-driven drug-discovery platform.

Forward Therapeutics, Inc.

CurieBio is a technology company specializing in the development of AI-driven software solutions for the life sciences industry. The company leverages machine learning to accelerate drug discovery and development, enabling researchers to predict and optimize small molecule properties, protein structures, and biological outcomes.

CurieBio

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

financial_statements

network_onboarding

company_summary

signals

regulatory_analysis

industry_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

swot_analysis

financial_analysis

news_advanced

purchaser_profile

news_impact_assignment_advanced

news_processing_advanced

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general
public peers	general	May 15, 2024 8:59 AM	74f9e34a
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
news advanced	general
news impact assignment advanced	general
news processing advanced	general
peers	general
news basic	general
events	markdown
bundesanzeiger	filings
financial statements	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
purchaser profile	merger_acquisitions
customer profile	customers

BIO:CURIE

CurieBio